Cargando…

The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications

Exosomes are extracellular vesicles released into biological fluids where they act as carriers of various molecules, including proteins, lipids, and RNAs, between cells, modulating or perturbing specific physiological processes. Recently, it has been suggested that tumoral cells release excessive am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingenito, Francesco, Roscigno, Giuseppina, Affinito, Alessandra, Nuzzo, Silvia, Scognamiglio, Iolanda, Quintavalle, Cristina, Condorelli, Gerolama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801421/ https://www.ncbi.nlm.nih.gov/pubmed/31546654 http://dx.doi.org/10.3390/ijms20194687

Ejemplares similares

Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer
por: Nuzzo, Silvia, et al.
Publicado: (2019)

miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment
por: Roscigno, Giuseppina, et al.
Publicado: (2020)

miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer
por: Palma, Francesco, et al.
Publicado: (2020)

Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer
por: Scognamiglio, Iolanda, et al.
Publicado: (2022)

Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer
por: Scognamiglio, Iolanda, et al.
Publicado: (2022)

Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study
por: Pane, Katia, et al.
Publicado: (2022)

Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment
por: Roscigno, Giuseppina, et al.
Publicado: (2020)

Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
por: Affinito, Alessandra, et al.
Publicado: (2020)

Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
por: Esposito, Carla Lucia, et al.
Publicado: (2021)

MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
por: Roscigno, Giuseppina, et al.
Publicado: (2017)

Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer
por: Donnarumma, Elvira, et al.
Publicado: (2017)

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
por: Iaboni, Margherita, et al.
Publicado: (2016)

RYK promotes the stemness of glioblastoma cells via the WNT/β-catenin pathway
por: Adamo, Assunta, et al.
Publicado: (2017)

The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
por: Affinito, Alessandra, et al.
Publicado: (2019)

miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS
por: Fiore, Danilo, et al.
Publicado: (2016)

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
por: Russo, Valentina, et al.
Publicado: (2018)

The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
por: Nuzzo, Silvia, et al.
Publicado: (2020)

miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
por: Quintavalle, Cristina, et al.
Publicado: (2013)

Recent Advance in Biosensors for microRNAs Detection in Cancer
por: Catuogno, Silvia, et al.
Publicado: (2011)

MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
por: Roscigno, Giuseppina, et al.
Publicado: (2015)

Selection of RNA aptamers targeting hypoxia in cancer
por: Nuzzo, Silvia, et al.
Publicado: (2022)

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer
por: Fortunato, Orazio, et al.
Publicado: (2019)

Antifouling Strategies of Nanoparticles for Diagnostic and Therapeutic Application: A Systematic Review of the Literature
por: Bevilacqua, Paolo, et al.
Publicado: (2021)

Novel Biomarkers for Contrast-Induced Acute Kidney Injury
por: Briguori, Carlo, et al.
Publicado: (2014)

Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2020)

Role of Nano-miRNAs in Diagnostics and Therapeutics
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Epigenetic Regulation of miR-212 Expression in Lung Cancer
por: Incoronato, Mariarosaria, et al.
Publicado: (2011)

Identification of Exo-miRNAs: A Summary of the Efforts in Translational Studies Involving Triple-Negative Breast Cancer
por: Encarnación-Medina, Jarline, et al.
Publicado: (2023)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

Reciprocal regulation of γ-globin expression by exo-miRNAs: Relevance to γ-globin silencing in β-thalassemia major
por: Sun, Kuo-Ting, et al.
Publicado: (2017)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
por: Wani, Javaid Ahmad, et al.
Publicado: (2022)

Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
por: Takada, Yukichi, et al.
Publicado: (2021)

Plasma Exo-miRNAs Correlated with AD-Related Factors of Chinese Individuals Involved in Aβ Accumulation and Cognition Decline
por: Wang, Lifang, et al.
Publicado: (2022)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Editorial: Exosomes, miRNAs, and lncRNAs in breast cancer: Therapeutic and diagnostic applications
por: Hashemi, Zahra Sadat, et al.
Publicado: (2023)

Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis
por: Hu, Liang-Hao, et al.
Publicado: (2015)

MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin
por: Samimi, Hilda, et al.
Publicado: (2013)

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
por: Alshahrani, Shadia Hamoud, et al.
Publicado: (2022)

MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73kr9rr26h1501n4b7oasv5hq9